Association of Non-Invasive Markers of Liver Fibrosis with HCV Coinfection and Antiretroviral Therapy in Patients with HIV
Open Access
- 12 July 2019
- journal article
- Published by Walter de Gruyter GmbH in Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
- Vol. 73 (4) , 400-402
Abstract
The aim of this study was to assess the main effects and interaction between viral hepatitis C (HCV) coinfection and antiretroviral therapy (ART) by using a nonparametric ANOVA on direct and indirect markers of liver fibrosis in HIV-infected patients. The sample included 178 HIV patients aged from 23 to 65 (36% females). The following parameters were determined in blood of patients: hyaluronic acid, pro-matrix metalloproteinase-1, alanine aminotransferase, aspartate aminotransferase, and platelet count. The FIB-4 index was also calculated. The nonparametric ANOVA revealed no significant interaction between HCV coinfection and ART. This provides evidence for an independent contribution of each factor on promotion of the pathology. The results also demonstrated that the direct and indirect indicators of liver fibrosis are associated differently with the studied factors. Therefore, a combination of markers should be used for monitoring of liver fibrosis in HIV-infected patients.Keywords
This publication has 12 references indexed in Scilit:
- Mechanisms of liver disease in patients infected with HIVBMJ Open Gastroenterology, 2017
- Poorly Controlled HIV Infection: An Independent Risk Factor for Liver FibrosisJAIDS Journal of Acquired Immune Deficiency Syndromes, 2016
- Hyaluronic acid as a non-invasive biomarker of liver fibrosisClinical Biochemistry, 2016
- Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: Prospective analysis of 435 liver biopsy pairsHepatology, 2013
- Rfit: Rank-based Estimation for Linear ModelsThe R Journal, 2012
- Hyaluronic Acid Levels Predict Increased Risk of Non-Aids Death in Hepatitis-Coinfected Persons Interrupting Antiretroviral Therapy in the Smart StudyAntiviral Therapy, 2011
- Robust Nonparametric Statistical Methods2010
- Noninvasive Diagnosis of Hepatic Fibrosis in HIV/HCV-Coinfected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfectionThe Lancet, 2003
- Liver BiopsyNew England Journal of Medicine, 2001